However, pathological in situ analysis of GBM TME revealed the activation of an adaptive immunosuppressive response by an enhanced infiltration of Tregs and expression of inhibitory molecules interleukin-10, PD-L1, and TFG-β [150]. The gene discussed is IL10; the disease is glioblastoma.